Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
769 studies found for:    "bladder cancer"
Show Display Options
Rank Status Study
1 Recruiting Biomarker Identification for Bladder Cancer Patients
Condition: Bladder Cancer
Intervention: Procedure: Sample Collection
2 Unknown  Screening for Bladder Cancer
Condition: Bladder Cancer
Intervention: Other: Specimen and questionnaires only
3 Completed Quality of Life and Symptom Management in Patients With Bladder Cancer
Condition: Bladder Cancer
Intervention:
4 Completed Health-Related Quality of Life in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: informational intervention;   Other: questionnaire administration;   Procedure: management of therapy complications;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
5 Unknown  NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.
Condition: Bladder Cancer
Intervention: Device: Use of Nuclear Matrix Protein 22 Urine sample kit to determine Bladder Cancer
6 Terminated Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Methotrexate;   Drug: Vinblastine;   Drug: Doxorubicin;   Drug: Cisplatin;   Drug: Gemcitabine
7 Completed Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Biological: BCG vaccine;   Drug: mitomycin C;   Radiation: radiation therapy
8 Recruiting Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Pembrolizumab;   Drug: Cisplatin;   Radiation: Radiotherapy
9 Completed Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: EOquin® (Apaziquone)
10 Completed The New England Bladder Cancer Study
Condition: Bladder Cancer
Intervention:
11 Completed Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Biological: keyhole limpet hemocyanin;   Drug: doxorubicin hydrochloride
12 Completed BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients
Condition: Bladder Cancer
Interventions: Biological: MAGE-A3 ASCI;   Biological: BCG
13 Active, not recruiting Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Erlotinib;   Procedure: Radical Cystectomy
14 Completed Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: methotrexate
15 Unknown  Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: medical chart review;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
16 Completed Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
17 Unknown  Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: chemoprevention
18 Completed Suramin in Treating Patients With Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: suramin;   Procedure: conventional surgery
19 Recruiting Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C
20 Active, not recruiting
Has Results
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: paclitaxel;   Radiation: radiation therapy;   Drug: Gemcitabine;   Procedure: Radical cystectomy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.